• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 06/23/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Zika

  • 1:25 PM

    ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its novel Zika vaccine development program. The grant award of $300,000 will fund the second year of a two-year project period with a total budget of $600,000.

    Read more
  • 9:40 AM

    SANDY, Utah–CODX, (BUSINESS WIRE)– Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today upcoming meetings with the Ministry of Public Health and Social Assistance (SESPAS) of the Dominican Republic to discuss the Company’s products. The meetings will take place the week of October 16, 2017, with senior officials of the Centro Nacional de Control de Enfermedades Tropicales (National Center of Control of Tropical Diseases,

    Read more
  • 6:15 PM

    WEST DES MOINES, Iowa, Dec. 13, 2016 /PRNewswire/ — Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company advancing technologies designed to address rare, emerging and neglected diseases, today announced that the Company has obtained from the Florida State University Research Foundation exclusive, worldwide rights to develop and commercialize certain compounds for the treatment of viral infections, including Zika virus infection. Included among the licensed compounds are those identified in a study1 co-authored by Florida State University Professor Hengli Tang that was

    Read more
  • 1:44 PM

    Supports Development of a Vaccine to Prevent Clade C HIV Prevalent in the Developing World ATLANTA, GA–GOVX, (Marketwired – Jun 29, 2016) – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in the development of human vaccines, announced today it has received a Notice of Award from the U.S. National Institutes of Health (NIH) for a Small Business Innovative Research (SBIR) grant in support of its clade C HIV vaccine development program for Africa. The grant award of $294,038

    Read more
  • 3:23 PM

    Collaboration With University of Georgia Infectious Disease Researchers Will Speed Development ATLANTA, GA– GOVX, (Marketwired – Feb 3, 2016) – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it has begun a program to develop a vaccine for the prevention of Zika virus infections using its novel MVA-VLP vaccine platform. The company believes that it can rapidly advance a vaccine candidate to human clinical testing. On February 1, 2016, the World Health Organization (WHO)

    Read more
  • 3:48 PM

    WALL, NJ– OTCQB, BKYI, (Marketwired – Nov 2, 2015) – BIO-key International, Inc. (OTCQB: BKYI), a leading fingerprint biometric identification software and technology provider, today reported that it has raised $8.45 million through the issuance of shares of its Series A-1 Convertible Preferred Stock. The preferred shares are convertible into common stock at a conversion price of $0.30 per share and were issued to a Hong Kong based security technology investor. Under the terms of the preferred shares, the investor

    Read more
Public Wire Banner